Garyric! Thanks for your post, YOU were one of the ones that have had iPPS and I forgot to mention when posting in the last few weeks. I knew there was at least one person I had forgotten to mention (It was nagging at me)...so apologies.
Yes good to get your thoughts and I agree with you. Though by the time it really hits the mass market I don't think the direct cost to the patient will be at all significant and yet we will get the full revenue. We just have to wait now!
Wabisabi - I'm not sure about that one, I doubt they would, as you suggest, as it would be akin to early results and outside a trial setting and clinical parameters, it will not carry the weight.
research reports and media, page-634
-
- There are more pages in this discussion • 3,655 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.015(4.84%) |
Mkt cap ! $103.1M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 29.5¢ | $86.19K | 286.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 70151 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 18600 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |